Income Statement
DOXIMITY, INC.
DOCS
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Mar 31, 2025 2024 FY | Mar 31, 2024 2023 FY | Mar 31, 2023 2022 FY | Mar 31, 2022 2021 FY |
|---|---|---|---|---|
|
Revenue
|
570.40 | 475.42 | 419.05 | 343.55 |
|
Cost of Revenue
|
55.87 | 50.67 | 53.49 | 39.79 |
|
Gross Profit
|
514.53 | 424.75 | 365.56 | 303.76 |
|
Operating Expenses
|
286.73 | 260.88 | 240.45 | 190.23 |
|
Research & Development
|
93.04 | 81.98 | 80.19 | 62.35 |
|
Selling, General & Administrative
|
145.71 | 133.13 | 123.52 | 92.13 |
|
Other Operating Expenses
|
- | - | - | - |
|
Operating Income
|
227.80 | 163.88 | 125.11 | 113.54 |
|
Non-Operating Income
|
-35.77 | -21.32 | -8.05 | -0.47 |
|
Interest Income
|
- | - | - | - |
|
Interest Expense
|
- | - | - | - |
|
Other Non-Op Income / Expense
|
-0.25 | 0.06 | 8.05 | 0.47 |
|
Income Before Tax
|
263.57 | 185.20 | 133.16 | 114.01 |
|
Income Tax Expense
|
40.39 | 37.62 | 20.34 | -40.78 |
|
Non-Controlling Interest
|
- | - | - | - |
|
Net Income
|
223.19 | 147.58 | 112.82 | 154.78 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Mar 31, 2025 2024 FY | Mar 31, 2024 2023 FY | Mar 31, 2023 2022 FY | Mar 31, 2022 2021 FY |
|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - |
|
EBITDA
|
238.46 | 174.14 | 135.39 | 118.58 |
|
Earnings Per Share (Basic)
|
1.19 | 0.78 | 0.58 | 0.82 |
|
Diluted EPS
|
1.11 | 0.72 | 0.53 | 0.70 |
|
Weighted Average Shares
|
186.84 | 190.17 | 193.18 | 163.48 |
|
Diluted Weighted Avg Shares
|
201.21 | 205.73 | 213.43 | 191.02 |
|
Comprehensive Income
|
227.17 | 159.00 | 114.03 | 139.51 |